(Q33375619)

English

Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702 (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

phase III clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

H Okamoto

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

K Watanabe

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

H Kunikane

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

A Yokoyama

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

S Kudoh

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

T Asakawa

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

T Shibata

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

H Kunitoh

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

T Tamura

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

N Saijo

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

19 June 2007

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

97

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

162-169

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360311

21 June 2018

Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360311

21 June 2018

Meta-analysis of randomized clinical trials comparing Cisplatin to Carboplatin in patients with advanced non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360311

21 June 2018

A statistical study of lung cancer in the annual of pathological autopsy cases in Japan, from 1958 to 1997, with reference to time trends of lung cancer in the world

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360311

21 June 2018

Carboplatin-etoposide combination in small cell lung cancer patients older than 70 years: a phase II trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360311

21 June 2018

Etoposide phosphate with carboplatin in the treatment of elderly patients with small-cell lung cancer: a phase II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360311

21 June 2018

Phase II study of area under the plasma-concentration-versus-time curve-based carboplatin plus standard-dose intravenous etoposide in elderly patients with small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360311

21 June 2018

Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360311

21 June 2018

Phase II trial of carboplatin plus oral etoposide for elderly patients with small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360311

21 June 2018

Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial. Medical Research Council Lung Cancer Working Party.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360311

21 June 2018

Toxicity grading criteria of the Japan Clinical Oncology Group. The Clinical Trial Review Committee of the Japan Clinical Oncology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360311

21 June 2018

Sequencing and schedule effects of cisplatin plus etoposide in small-cell lung cancer: results of a North Central Cancer Treatment Group randomized clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360311

21 June 2018

Carboplatin/etoposide combination chemotherapy in the treatment of poor prognosis patients with small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360311

21 June 2018

Retrospective review of chemotherapy for small cell lung cancer in the elderly: does the end justify the means?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360311

21 June 2018

Interim analysis: the alpha spending function approach.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603810

21 January 2018

Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and Leukemia Group B Trial 9732.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603810

21 January 2018

Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603810

21 January 2018

Combination chemotherapy with low doses of weekly Carboplatin and oral Etoposide in poor risk small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603810

21 January 2018

Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603810

21 January 2018

Similar outcome of elderly patients in intergroup trial 0096: Cisplatin, etoposide, and thoracic radiotherapy administered once or twice daily in limited stage small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603810

21 January 2018

Platinum-etoposide chemotherapy in elderly patients with small-cell lung cancer: results of a randomized multicenter phase II study assessing attenuated-dose or full-dose with lenograstim prophylaxis--a Forza Operativa Nazionale Italiana Carcinoma P

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360311

31 October 2018

Re: Five-Day Oral Etoposide Treatment for Advanced Small-Cell Lung Cancer: Randomized Comparison With Intravenous Chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603810

21 January 2018

A combination chemotherapy of carboplatin and irinotecan with granulocyte colony-stimulating factor (G-CSF) support in elderly patients with small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17579629

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nomograms for calculating the number of patients needed for a clinical trial with survival as an endpoint

1 reference

https://pubmed.ncbi.nlm.nih.gov/17579629

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predicting septic complications of chemotherapy: an analysis of 382 patients treated for small cell lung cancer without dose reduction after major sepsis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17579629

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral etoposide and carboplatin. Effective therapy for elderly patients with small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17579629

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of age on the treatment of limited-stage small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17579629

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New combination of the old drugs for elderly patients with small-cell lung cancer: a phase II study of the PAVE regimen

1 reference

https://pubmed.ncbi.nlm.nih.gov/17579629

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abbreviated treatment for elderly, infirm, or noncompliant patients with limited-stage small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17579629

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6603810

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33375619&oldid=2195300895"